par Garcia, Camilo ;Gebhart, Géraldine ;Flamen, Patrick
Référence Current opinion in oncology, 24, 6, page (748-755)
Publication Publié, 2012-11
Article révisé par les pairs
Résumé : (18)F-fluoro-2-deoxy-D-glucose PET-computed tomography (CT) has a major clinical impact in oncology not only for diagnostics but also for staging, response assessment, and relapse detection. However, several other PET tracers are needed for a more complete molecular characterization of cancers which has great importance in the era of individualized targeted therapies. PET-CT is an exquisite tool for molecular imaging because it allows detection of nanomolar quantities of tracer molecules targeting different hallmarks of cancer.